Solomon H. Snyder

Last updated
Solomon H. Snyder
Solomon H. Snyder.jpg
in 1979
BornDecember 26, 1938 (1938-12-26) (age 85)
Washington D.C
Education Georgetown University
Awards Albert Lasker Award for Basic Medical Research,
National Medal of Science
Scientific career
FieldsNeuroscientist
Psychiatrist
Doctoral advisor Julius Axelrod [1]

Solomon Halbert Snyder (born December 26, 1938) is an American neuroscientist who has made wide-ranging contributions to neuropharmacology and neurochemistry. He studied at Georgetown University, and has conducted the majority of his research at the Johns Hopkins School of Medicine. Many advances in molecular neuroscience have stemmed from Snyder's identification of receptors for neurotransmitters and drugs, and elucidation of the actions of psychotropic agents. [2] He received the Albert Lasker Award for Basic Medical Research in 1978 for his research on the opioid receptor, and is one of the most highly cited researchers in the biological and biomedical sciences, with the highest h-index in those fields for the years 1983–2002, [3] and then from 2007 to 2019.

Contents

Biography

Personal life

Solomon Snyder was born on December 26, 1938, in Washington D.C. He is one of five children. [2] Snyder and his wife Elaine, who died in 2016, have two daughters and three grandchildren. He lives in Baltimore, Maryland.

Education and early career

Snyder attended Georgetown University from 1955 to 1958 and received his M.D. degree from Georgetown University School of Medicine in 1962. After a medical residency at the Kaiser Hospital in San Francisco, he served as a research associate from 1963 to 1965 at the National Institutes of Health, where he studied under Julius Axelrod. Snyder moved to the Johns Hopkins University School of Medicine to complete his residency in psychiatry from 1965 to 1968. He was appointed to the faculty there in 1966 as Assistant Professor of Pharmacology. In 1968 he was promoted to associate professor of Pharmacology and Psychiatry and in 1970 to full professor in both departments.

His laboratory is noted for the use of receptor binding studies to characterize the actions of neurotransmitters and psychoactive drugs.

He is also known for his work identifying receptors for the major neurotransmitters in the brain, and in the process explaining the actions of psychoactive drugs, such as the blockade of dopamine receptors by antipsychotic medications. He has described novel neurotransmitters, such as the gases nitric oxide and carbon monoxide and the D-isomers of amino acids, including D-serine.

Later career

Snyder was University Distinguished Service Professor of Neuroscience, Pharmacology, and Psychiatry at the Johns Hopkins University School of Medicine. In 1980, he founded the Department of Neuroscience, and served as its first director from 1980 to 2006. In 2006, the department was renamed as The Solomon H. Snyder Department of Neuroscience in his honor. Snyder retired from Johns Hopkins in December 2022. [4]

Snyder is also the Director of Drug Discovery at the Lieber Institute for Brain Development in Baltimore, MD. [5]

In 1980, he served as the president of the Society for Neuroscience. He is also associate editor, Proceedings of the National Academy of Sciences of the United States of America . He helped start the companies Nova Pharmaceuticals and Guilford Pharmaceuticals, and has been an active philanthropist.[ citation needed ]

He is listed by the Institute for Scientific Information as one of the 10 most-often cited biologists and he also has the highest h-index of any living biologist.

Awards

Related Research Articles

<span class="mw-page-title-main">Neurotransmitter</span> Chemical substance that enables neurotransmission

A neurotransmitter is a signaling molecule secreted by a neuron to affect another cell across a synapse. The cell receiving the signal, or target cell, may be another neuron, but could also be a gland or muscle cell.

<span class="mw-page-title-main">Psychopharmacology</span> Study of the effects of psychoactive drugs

Psychopharmacology is the scientific study of the effects drugs have on mood, sensation, thinking, behavior, judgment and evaluation, and memory. It is distinguished from neuropsychopharmacology, which emphasizes the correlation between drug-induced changes in the functioning of cells in the nervous system and changes in consciousness and behavior.

<span class="mw-page-title-main">Candace Pert</span> American neuroscientist (1946–2013)

Candace Beebe Pert was an American neuroscientist and pharmacologist who discovered the opioid receptor, the cellular binding site for endorphins in the brain.

<span class="mw-page-title-main">George Aghajanian</span> Pioneer in neuropharmacology (1932–2023)

George K. Aghajanian was an American psychiatrist who was Emeritus Foundations Fund Professor at the Yale School of Medicine, New Haven, Connecticut, in the Department of Psychiatry. He was a pioneer in the area of neuropharmacology. He also served as a member of the NARSAD Scientific Advisory Board.

<span class="mw-page-title-main">George Koob</span> American academic

George F. Koob is a Professor and former Chair of the Committee on the Neurobiology of Addictive Disorders at the Scripps Research Institute and Adjunct Professor of Psychology, Psychiatry, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. In 2014 he became the director of the National Institute on Alcohol Abuse and Alcoholism.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

<span class="mw-page-title-main">Bernard Beryl Brodie</span> American biochemist

Bernard Beryl Brodie was a founding scientist in the area of biochemical and neurochemical pharmacology whose work in the 1940s and 1950s had great impact. He was a major figure in the fields of drug metabolism and drug therapy, studying how the absorption and interactions of drugs in the body. Brodie helped to found and lead the Laboratory of Chemical Pharmacology at the National Heart Institute in Bethesda, Maryland, one of the National Institutes of Health. He was a member of the United States National Academy of Sciences.

Erminio "Mimo" Costa was an Italian-American neuroscientist. His research interests covered brain serotonergic activity in health and disease, benzodiazepine-GABA interactions, benzodiazepine action at GABAA receptors, neurophysiological role of neurosteroids, and GABAergic dysfunction and changes in the expression of reelin and GAD67 in schizophrenia. He published more than 1,000 articles. The June 2011 issue of the journal Neuropharmacology was dedicated to him.

<span class="mw-page-title-main">Jeffrey Lieberman</span> American psychiatrist (born 1948)

Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.

<span class="mw-page-title-main">Anne B. Young</span> American neuroscientist

Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases, with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.

<span class="mw-page-title-main">Thomas C. Südhof</span> German-American biochemist

Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.

<span class="mw-page-title-main">Huda Akil</span> Syrian-American neuroscientist (born 1945)

Huda Akil is a Syrian-American neuroscientist whose research has contributed to the understanding of the neurobiology of emotions, including pain, anxiety, depression, and substance abuse. Akil and her colleagues are best known for providing the first physiological evidence for a role of endorphins in the brain and demonstrating that endorphins are activated by stress and can cause pain inhibition.

<span class="mw-page-title-main">Psychoactive drug</span> Chemical substance that alters nervous system function

A psychoactive drug, psychopharmaceutical, psychoactive agent, or psychotropic drug is a chemical substance that changes the function of the nervous system and results in alterations of perception, mood, cognition, and behavior. These substances may be used medically, recreationally, for spiritual reasons, or for research. Some categories of psychoactive drugs may be prescribed by physicians and other healthcare practitioners because of their therapeutic value.

Michael J. Kuhar, is an American neuroscientist, author, and Candler Professor of Neuropharmacology at The Emory National Primate Research Center of Emory University. He is a Georgia Research Alliance eminent scholar, and a senior fellow in the Center for Ethics at Emory. He was previously a professor at Johns Hopkins University School of Medicine and branchchief at the National Institute on Drug Abuse.

David S. Bredt is an American molecular neuroscientist.

<span class="mw-page-title-main">Susan Amara</span> American neuroscientist

Susan G. Amara is an American professor of neuroscience and is the Scientific Director of the National Institute of Mental Health. Dr. Amara is an elected member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science. She is a Past-President of the Society for Neuroscience. Dr. Amara has a B.S. in Biological Sciences from Stanford University and a Ph.D. in Physiology and Pharmacology from the University of California, San Diego.

<span class="mw-page-title-main">Patricia Janak</span> American neuroscientist (born 1965)

Patricia Janak is a Bloomberg Distinguished Professor at Johns Hopkins University who studies the biological basis of behavior through associative learning. Janak applies this research to pathological behaviors, such as addiction and posttraumatic stress disorder, to improve understanding of how stimuli affect relapse and responses.

John Hughes is a British neuroscientist who shared the 1978 Albert Lasker Award for Basic Medical Research for the discovery of met-enkephalin and leu-enkephalin. This discovery demonstrated that opiate drugs exert their effects on the human brain by mimicking endogenous neurotransmitters, the opioid peptides.

<span class="mw-page-title-main">Olivier Civelli</span> Molecular biologist

Olivier Civelli is a molecular biologist, a researcher in the field of neuropharmacology and an educator. He is the Eric L. and Lila D. Nelson Professor of Neuropharmacology at University of California, Irvine. He is also a Professor in the Department of Developmental and Cell Biology at University of California, Irvine. He is most known for his work in advancing understanding of neurotransmission and his impact on drug discovery.

Joseph Thomas Coyle Jr. is an American psychiatrist and neuroscientist. He is the Eben S. Draper Professor of Psychiatry and Neuroscience at Harvard Medical School.

References

  1. "Solomon Snyder".
  2. 1 2 3 4 5 6 "Solomon H. Snyder, M.D., Vice Chairman for Science". Archived from the original on February 25, 2015. Retrieved February 25, 2015.
  3. Hirsh, J. E. (November 15, 2005). "An index to quantify an individual's scientific research output". Proc Natl Acad Sci USA. 102 (46): 16569–16572. arXiv: physics/0508025 . Bibcode:2005PNAS..10216569H. doi: 10.1073/pnas.0507655102 . PMC   1283832 . PMID   16275915.
  4. "Solomon Snyder, JHU distinguished professor emeritus and noted neurologist and psychologist, retires". Solomon H. Snyder Department of Neuroscience. 2022-12-08. Retrieved 2024-01-16.
  5. "The Lieber Institute for Brain Development - Research & Discovery". www.libd.org. Retrieved 7 April 2018.
  6. "Golden Plate Awardees of the American Academy of Achievement". www.achievement.org. American Academy of Achievement.
  7. Holden, Constance (1991). Science. Vol. 253. American Association for the Advancement of Science. p. 1485. JSTOR   2884974.

Further reading